Article Information
vol. 8 no. 4
Published By
Online ISSN
History
- Received May 17, 2022
- Accepted August 25, 2022
- Published online October 24, 2022.
Article Versions
- previous version (September 16, 2022 - 05:57).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Nora Drick1,2,4,
- Jan Fuge1,2,4⇑,
- Benjamin Seeliger1,2,
- Milan Speth3,
- Jens Vogel-Claussen2,3,
- Tobias Welte1,2 and
- Hendrik Suhling1,2
- 1Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany
- 2Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany
- 3Institute for Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany
- 4These authors contributed equally
- Corresponding author: Jan Fuge (fuge.jan{at}mh-hannover.de)
Article usage
Altmetrics
Vol 8 Issue 4
Table of Contents
Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD
